Login / Signup

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.

Claudia CicognolaShorena JanelidzeJoakim HertzeHenrik ZetterbergKaj BlennowNiklas Mattsson-CarlgrenOskar Hansson
Published in: Alzheimer's research & therapy (2021)
Plasma GFAP can detect AD pathology in patients with MCI and predict conversion to AD dementia.
Keyphrases
  • mild cognitive impairment
  • cognitive decline
  • ionic liquid
  • amino acid
  • spinal cord injury
  • spinal cord
  • cognitive impairment